Home Companies AstraZeneca

AstraZeneca

    Latest
    AstraZeneca

    AstraZeneca to Acquire Alexion for $39B, Adding Rare Disease, Immunology Assets

    AstraZeneca

    AstraZeneca-Oxford COVID-19 Vaccine Shows Positive Phase II Results

    Flu Vaccination
    AstraZeneca

    U.S. Army Awards $599M in Contracts for AstraZeneca Vaccine, Lilly Antibody...

    Coronavirus 2019-nCoV spreading
    AstraZeneca

    AstraZeneca, J&J Resuming Phase III COVID-19 Vaccine Trials

    Senior male is about to receive Covid-19 coronavirus vaccine
    AstraZeneca

    COVID-19: AstraZeneca, U. of Oxford Resume Phase III Trial; Pfizer, BioNTech...

    AstraZeneca

    AstraZeneca Pauses Phase III COVID-19 Vaccine Trial, Citing “Potentially Unexplained Illness”

    AstraZeneca

    As Pressure Mounts, CEOs Commit to Science, Safety in Developing COVID-19...

    AstraZeneca

    AstraZeneca Launches 30,000-Patient Phase III U.S. Trial of COVID-19 Vaccine

    AstraZeneca

    AstraZeneca, Daiichi Sankyo Target TROP2 in Up-to-$6B Cancer Collaboration

    AstraZeneca

    Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch

    123...5Page 1 of 5
    Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.